Prediction of pre-eclampsia in diabetic pregnant women

被引:0
作者
Kumar, Ashok [1 ,2 ]
Vanamail, Perumal [3 ]
Gupta, Ram Kumar [1 ,2 ]
Husain, Syed Akhtar [4 ]
机构
[1] Maulana Azad Med Coll, Dept Obstetr & Gynaecol, New Delhi, India
[2] Lok Nayak Hosp, New Delhi, India
[3] Jamia Millia Islamia, All India Inst Med Sci, New Delhi, India
[4] Jamia Millia Islamia, Dept Bio Sci, New Delhi, India
关键词
Diabetes mellitus; gestational diabetes mellitus; pre-eclampsia; pregnancy; PLACENTAL GROWTH-HORMONE; 20 WEEKS GESTATION; INSULIN-RESISTANCE; RISK-FACTOR; MELLITUS; OUTCOMES; PROTEIN;
D O I
10.4103/ijmr.IJMR_1594_19
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: Gestational or preexisting diabetes is one of the risk factors of pre-eclampsia. Both are responsible for higher maternal and fetal complications. The objective was to study clinical risk factors of pre-eclampsia and biochemical markers in early pregnancy of women with diabetes mellitus (DM)/gestational diabetes mellitus (GDM) for the development of pre-eclampsia. Methods: The study group comprised pregnant women diagnosed with GDM before the 20 wk of gestation and DM before pregnancy and the control group had age-, parity- and period of gestation-matched healthy women. Sex hormone-binding globulin (SHBG), insulin-like growth factor-I (IGF-I) and 25-hydroxy vitamin D [25(OH)D] levels and the polymorphism of these genes was evaluated at recruitment. Results: Out of 2050 pregnant women, 316 (15.41%) women (296 had GDM and 20 DM before pregnancy) were included in the study group. Of these, 96 women (30.38%) in the study group and 44 (13.92%) controls developed pre-eclampsia. Multivariate logistic regression analysis indicated those who belonged to the upper middle and upper class of socio-economic status (SES) were likely to be at 4.50 and 6.10 times higher risk of developing pre-eclampsia. The risk of getting pre-eclampsia among those who had DM before pregnancy and pre-eclampsia in their previous pregnancy was about 2.34 and 4.56 times higher compared to those who had no such events, respectively. The serum biomarkers [SHBG, IGF-I and 25(OH)D] were not found to be useful in predicting pre-eclampsia in women with GDM. To predict risk of development of pre-eclampsia, the fitted risk model by backward elimination procedure was used to calculate a risk score for each patient. Receiver operating characteristic (ROC) curve for pre-eclampsia showed that area under the curve was 0.68 (95% confidence interval: 0.63-0.73); P<0.001. Interpretation & conclusions: The findings of this study suggested that pregnant women with diabetes were at a higher risk for pre-eclampsia. SES, history of pre-eclampsia in previous pregnancy and pre-GDM were found to be the risk factors.
引用
收藏
页码:330 / 344
页数:15
相关论文
共 36 条
  • [1] Classification and Diagnosis of Diabetes
    不详
    [J]. DIABETES CARE, 2015, 38 : S8 - S16
  • [2] Pregnancy Outcomes in Women With and Without Gestational Diabetes Mellitus According to The International Association of the Diabetes and Pregnancy Study Groups Criteria
    Bodmer-Roy, Sonja
    Morin, Lucie
    Cousineau, Jocelyne
    Rey, Evelyne
    [J]. OBSTETRICS AND GYNECOLOGY, 2012, 120 (04) : 746 - 752
  • [3] Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction
    Brownfoot, Fiona C.
    Hastie, Roxanne
    Hannan, Natalie J.
    Cannon, Ping
    Tuohey, Laura
    Parry, Laura J.
    Senadheera, Sevvandi
    Illanes, Sebastian E.
    Kaitu'u-Lino, Tu'uhevaha J.
    Tong, Stephen
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (03) : 356.e1 - 356.e15
  • [4] Sex-hormone-binding globulin early in pregnancy for the prediction of severe gestational diabetes mellitus and related complications
    Caglar, Gamze S.
    Ozdemir, Elif D. U.
    Cengiz, Sevim D.
    Demirtas, Selda
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2012, 38 (11) : 1286 - 1293
  • [5] Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction
    Christians, Julian K.
    Gruslin, Andree
    [J]. PRENATAL DIAGNOSIS, 2010, 30 (09) : 815 - 820
  • [6] Increasing prevalence of gestational diabetes mellitus
    Ferrara, Assamrpa
    [J]. DIABETES CARE, 2007, 30 : S141 - S146
  • [7] Prediction of gestational diabetes mellitus at 24 to 28 weeks of gestation by using first-trimester insulin sensitivity indices in Asian Indian subjects
    Grewal, Emmy
    Kansara, Sandeep
    Kachhawa, Garima
    Ammini, A. C.
    Kriplani, Alka
    Aggarwal, Nutan
    Gupta, Nandita
    Khadgawat, Rajesh
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2012, 61 (05): : 715 - 720
  • [8] Maternal insulin resistance and preeclampsia
    Hauth, John C.
    Clifton, Rebecca G.
    Roberts, James M.
    Myatt, Leslie
    Spong, Catherine Y.
    Leveno, Kenneth J.
    Varner, Michael W.
    Wapner, Ronald J.
    Thorp, John M., Jr.
    Mercer, Brian M.
    Peaceman, Alan M.
    Ramin, Susan M.
    Carpenter, Marshall W.
    Samuels, Philip
    Sciscione, Anthony
    Tolosa, Jorge E.
    Saade, George
    Sorokin, Yoram
    Anderson, Garland D.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (04) : 327.e1 - 327.e6
  • [9] Prediction of gestational diabetes mellitus at first trimester in low-risk pregnancies
    Kumru, Pinar
    Arisoy, Resul
    Erdogdu, Emre
    Demirci, Oya
    Kavrut, Mustecep
    Ardic, Cern
    Aslaner, Nihan
    Ozkoral, Aysen
    Ertekin, Aktug
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2016, 55 (06): : 815 - 820
  • [10] Screening and diagnosis of gestational diabetes in India: a systematic review and meta-analysis
    Li, Katherine T.
    Naik, Shilpa
    Alexander, Mallika
    Mathad, Jyoti S.
    [J]. ACTA DIABETOLOGICA, 2018, 55 (06) : 613 - 625